Onesource said Orbicular Pharma with its US-based front-end partner have secured the US Food and Drug administration (USFDA) ...
Hyderabad-based Orbicular Pharmaceutical Technologies announced that its generic version of Ozempic (semaglutide injection), developed with Apotex, has received tentative approval from the USFDA. The ...
Orbicular's partner secures tentative US FDA approval for generic version of Ozempic: Our Bureau, Bengaluru Tuesday, April 21, 2026, 14:20 Hrs [IST] OneSource Specialty Pharma’s ...
The approval by the US Food and Drug Administration (USFDA) is for dapagliflozin tablets of strengths 5 mg and 10 mg, Biocon ...
10d
Orbicular gets USFDA’s tentative nod for generic Semaglutide Injection in partnership with Apotex
Orbicular receives USFDA tentative approval for generic Semaglutide Injection, partnering with Apotex for U.S.
Apotex Corp. today announced it has received the first U.S. Food and Drug Administration (FDA) Tentative Approval for its Abbreviated New Drug Application (ANDA) for Semaglutide Injection, marking a ...
Alembic Pharmaceuticals secures USFDA approval for generic Methotrexate injection, boosting its oncology portfolio and strengthening its presence in the US generics market.
Future Outlook With ANDA approval secured, Bionpharma will lead the commercialization and distribution of Etravirine tablets in the United States. Both organizations view this achievement as a solid ...
Orbicular Pharma and Apotex receive tentative US FDA approval for generic Ozempic, marking entry into the fast-growing ...
Lupin Limited has received approval from the United States Food and Drug Administration (USFDA) for its Dapagliflozin and ...
Partner Apotex Corp. (Apotex) to market and distribute to the U.S. healthcare market ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results